BOSTON–(BUSINESS WIRE)– #HAIpump–Intera Oncology® Inc., manufacturer of the only FDA-approved pump for Hepatic Artery Infusion (HAI) therapy for the treatment of intrahepatic cholangiocarcinoma (bile duct cancer confined to the liver) and colorectal cancer liver metastases, will showcase its Intera 3000 HAI pump as a sponsor of the 10th annual Cholangiocarcinoma Foundation Conference April 12 to 15 in Salt Lake City, Utah. Intrahepatic cholangiocarcinoma (IHCC) has a very poor prognosis and patients tr
Click here to view original post
News
The Greatest of All Gifts – Organ Donation
Beverly Hurwitz’s newest novel peeks into the world of transplants PARK CITY, Utah, Dec. 17, 2024 /PRNewswire/ — When a troubled teenager has a fatal car accident, a young mother hopes that her child’s donated […]
News
BlueWind Medical Announces Peer-Reviewed Data Showing Excellent Durability of Results for Revi® System at Two Years
PARK CITY, Utah–(BUSINESS WIRE)–BlueWind Medical, Ltd., a leader in implantable Tibial NeuroModulation (iTNM) and developer of the Revi® System, a patient-centric solution for urgency urinary incontinence (UUI), announced today the publication of two-year results from […]
News
Japan Communications Contracted with the State of Utah, USA to Facilitate Implementation of Statewide CBRS (local 4/5G) for Educational and Telehealth Network
DENVER, Dec. 15, 2023 /PRNewswire/ — Japan Communications Inc. (JCI) is pleased to announce that its United States (US) subsidiary JCI US Inc. (JCI US) has entered into a contract with the State of Utah […]
